The Gestational Effects of Maternal Bone Marker Molecules on Fetal Growth, Metabolism and Long-Term Metabolic Health: A Systematic Review
Fetal exposure in adverse environmental factors during intrauterine life can lead to various biological adjustments, affecting not only in utero development of the conceptus, but also its later metabolic and endocrine wellbeing. During human gestation, maternal bone turnover increases, as reflected...
Main Authors: | Angelos Dimas, Anastasia Politi, Alexandra Bargiota, Theodoros Panoskaltsis, Nikolaos F. Vlahos, Georgios Valsamakis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/15/8328 |
Similar Items
-
Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease
by: Vladimir Gerov, et al.
Published: (2023-11-01) -
Osteoprotegerin, sclerostin, and osteocalcin serum levels in thyroid disorder patients
by: F. F. Rija, et al.
Published: (2021-10-01) -
Serum sRAGE, sRANKL and osteoprotegerin in subgroups of rheumatoid arthritis patients: biomarkers associated with iron and disease status
by: Ginka Delcheva, et al.
Published: (2023-12-01) -
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
by: Riham Eid, et al.
Published: (2023-06-01) -
The Dynamic Role of PD-1, Vitamin D, RANKL, and Sclerostin in Iraqi Patients with Systemic Lupus Erythematosus
by: Anwar Khalil Ismael, et al.
Published: (2024-01-01)